Is Genome Editing the Next Step in Immunotherapy Innovation? Experts Think So
Presenters at the American Society of Hematology Annual Meeting and Exposition agreed that novel strategies, such as CRISPR and base editing, have potential to fine-tune the latest immunotherapy advancements to increase the efficacy and durability of a range of treatments.
United States Alexander Marson Dans Kaufman Chiara Bonini Alpha Tauri American Society Of Hematology Annual Meeting
Source: ajmc.com